how did the ethics board approve a placebo in this study? Anyway a 70% decrease in vertebral fractures is impressive over 3 years and , for a change, resource-light for those of us working in LTC
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
skip to main |
skip to sidebar
news stories and sundry information relevant to busy physicians and other health care providers interested in long term care.
No comments:
Post a Comment